Hongji Li
127 West Changle Road
Xi'an, 710032, China
Xi'an, 710032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Cholesterol-Mediated Metabolic-mechanotransductive Crosstalk Orchestrates Castration Resistance in Prostate Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 24, 2026
Active-targeting biomimetic nanosystem for prostate cancer enhances radiotherapy efficacy by inducing ferroptosis.
Journal: Journal of nanobiotechnology
Published: September 12, 2025
Organic-Inorganic Modification of PVDF Membranes by PDA@ZnO and PDA@MgO Nanoparticles for Enhanced Performance of Organic Dye Wastewater Treatment.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: March 06, 2025
LHX2 Rewires the Metabolic and Epigenetic Landscape to Drive Tumor Progression in Prostate Cancer.
Journal: Cancer research
Published: February 07, 2025
Salidroside mitigates Oligoasthenospermia by attenuating ferroptosis via NF-κB pathway inhibition.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 08, 2024
Genetically Engineered Membrane-Coated Nanoparticles for Enhanced Prostate-Specific Membrane Antigen Targeting and Ferroptosis Treatment of Castration-Resistant Prostate Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 30, 2024
Macrophage-Derived Nanosponges Adsorb Cytokines and Modulate Macrophage Polarization for Renal Cell Carcinoma Immunotherapy.
Journal: Advanced healthcare materials
Published: January 25, 2024
Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma.
Journal: Frontiers in genetics
Published: August 17, 2022
CD248 as a bridge between angiogenesis and immunosuppression: a promising prognostic and therapeutic target for renal cell carcinoma.
Journal: Annals of translational medicine
Published: November 15, 2021
CD248+ Cancer-Associated Fibroblasts: A Novel Prognostic and Therapeutic Target for Renal Cell Carcinoma.
Journal: Frontiers in oncology
Published: October 11, 2021
Last Updated: 09/26/2026